Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 2 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 3 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 4 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 5 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 6 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 7 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 8 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 [2] JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 9 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 10 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 11 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 12 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 13 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 14 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 15 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 16 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 17 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 18 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 19 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 20 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 21 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 22 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 23 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 24 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 [3] JAK1, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 25 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 26 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 27 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 28 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 29 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 30 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 31 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 32 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 33 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 34 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 35 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 36 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 37 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 38 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 39 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 40 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 [2] JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 41 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 42 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 43 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 44 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 45 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 46 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 47 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 48 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 [3] JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 49 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 50 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 51 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 52 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 53 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 54 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 55 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 56 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 57 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 58 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 59 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 60 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 61 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 62 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 63 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 64 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 [2] JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 65 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 66 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 67 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 68 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 69 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 70 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 71 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 72 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 73 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 74 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 75 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 76 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 77 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 78 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 79 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 80 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 [3] JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 81 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 82 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 83 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 84 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 85 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 86 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 87 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 88 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 89 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 90 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 91 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 92 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 93 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 94 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 95 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 96 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 [3] JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 97 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 98 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 99 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 100 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 101 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 102 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 103 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 104 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 105 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 106 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 107 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 108 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 109 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 110 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 111 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 112 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 [3] JAK1, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 113 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 114 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 115 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 116 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 117 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 118 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 119 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 120 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 121 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 122 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 123 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 124 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 125 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 126 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 127 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 128 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 [2] JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 129 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 130 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 131 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 132 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 133 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 134 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 135 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 136 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 [2] JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 137 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 138 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 139 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 140 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 141 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 142 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 143 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 144 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 145 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 146 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 147 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 148 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 149 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 150 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 151 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 152 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 153 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 154 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 155 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 156 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 157 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 158 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 159 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 160 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 161 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 162 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 163 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 164 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 165 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 166 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 167 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 168 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 169 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 170 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 171 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 172 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 173 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 174 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 175 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 176 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 177 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 178 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 179 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 180 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 181 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 182 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 183 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 184 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 185 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 186 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 187 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 188 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 189 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 190 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 191 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [3] JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 192 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 193 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 194 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 195 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 196 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 197 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 198 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 199 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 200 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [3] JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 201 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 202 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 203 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 204 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 205 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 206 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 207 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 208 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 209 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 [1] 84 💬
|
| 210 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 [13] 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 211 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 [6] 46, 53, 96, 97, 222, 271 💬
|
| 212 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 [4] 46, 51, 97, 228 💬
|
| 213 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 [3] 60, 65, 228 💬
|
| 214 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [1] JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 [8] 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 215 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 [1] 46 💬
|
| 216 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases |
JAK1 [2] JAK1, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|